Emiko Sakaida
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 180 publications
Thiotepa-busulfan-fludarabine conditioning in allogeneic hematopoietic stem cell transplantation for blast-phase myeloproliferative neoplasm
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Prolonged engraftment syndrome following autologous stem cell transplantation in Hodgkin lymphoma with prior immune checkpoint inhibitor therapy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Association between the Pharmacokinetic Parameters of Ganciclovir and Clinical Efficacy and Safety in the Treatment of Cytomegalovirus Infection.
Journal: Biological & pharmaceutical bulletin
Published: August 23, 2026
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: August 23, 2026
Workforce Entry and Employment Trajectories among Adolescent and Young Adult Hematopoietic Cell Transplant Survivors without Prior Employment.
Journal: Transplantation and cellular therapy
Published: June 23, 2026
Overview
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: June 03, 2026
Mentorship to support career development among women physicians
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 13, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.
Journal: Blood advances
Published: May 05, 2026
Body Mass Index and Outcomes after CD19 Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: A Nationwide Registry Study.
Journal: Transplantation and cellular therapy
Published: April 27, 2026
Treatment outcomes of adult B-cell ALL with post-transplant relapse in the era of immunotherapeutic agents.
Journal: Transplantation and cellular therapy
Published: March 24, 2026
Reattempt of tyrosine kinase inhibitor discontinuation after maintenance therapy with ponatinib in patients with chronic myeloid leukaemia in the chronic phase: Result of the Japan Adult Leukemia Study Group RE-STOP219 study.
Journal: British journal of haematology
Published: March 12, 2026
Last Updated: 09/26/2026